SCHEMBL18873296

SCHEMBL18873296

CC(C)c1ccc(SF)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 2/20 0.41
LMNA P02545 4/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTT P42858 2/20 0.38
MCL1 Q07820 2/20 0.38
BCL2 P10415 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
IDO1 P14902 2/20 0.37
HIF1A Q16665 2/20 0.37
GAA P10253 2/20 0.37
ALOX12 P18054 1/20 0.37
USP5 P45974 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
FKBP1A P62942 1/20 0.36
AGBL2 Q5U5Z8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL944020 0.78 TYR (0.44) TYRLMNAALDH1A1MAPTPKM
SCHEMBL2279013 0.78 MCL1 (0.53) TYRLMNAALDH1A1HTTMCL1
SCHEMBL104124 0.76 TYR (0.58) TYRLMNAALDH1A1HTTIDO1
SCHEMBL4556108 0.76 SLC6A4 (0.52) TYRALDH1A1HTT
SCHEMBL10012057 0.76 HTT (0.44) TYRLMNAALDH1A1MAPTPKM
SCHEMBL13831900 0.75 SMN1; SMN2 (0.60) TYRLMNAALDH1A1MAPTPKM
SCHEMBL2022129 0.74 TYR (0.41) TYRLMNAALDH1A1MAPTPKM
SCHEMBL21155778 0.74 TYR (0.41) TYRLMNAALDH1A1MAPTPKM
SCHEMBL6366693 0.74 HTT (0.43) TYRALDH1A1HTTMCL1BCL2
SCHEMBL11312641 0.74 TYR (0.41) TYRLMNAALDH1A1MAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3167887-B1 ARYL AMINE SUBSTITUTED QUINOXALINE USED AS ANTICANCER DRUGS CHEN KUENFENG (TW) 2021-03-24 EP disclosed
EP-3167887-A1 ARYL AMINE SUBSTITUTED QUINOXALINE USED AS ANTICANCER DRUGS Chen, Kuenfeng (TW) 2017-05-17 EP disclosed